NYSE:BSX

Boston Scientific Stock News

etoro logo Buy BSX
*Your capital is at risk
$47.69
+0.0100 (+0.0210%)
At Close: Jun 03, 2026
Dana Investment Advisors Inc. lessened its position in Boston Scientific Corporation (NYSE: BSX) by 53.7% in the undefined quarter, according to the company in its most recent filing with the SEC. The
New York, New York--(Newsfile Corp. - February 23, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation
MARLBOROUGH, Mass., Feb. 23, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Cathy Smith and Christophe Weber to its Board of Directors, effective Februa
Bleakley Financial Group LLC increased its stake in Boston Scientific Corporation (NYSE: BSX) by 9.0% during the third quarter, according to its most recent filing with the Securities and Exchange Com
Alliance Wealth Advisors LLC UT increased its position in Boston Scientific Corporation (NYSE: BSX) by 207.7% in the undefined quarter, according to its most recent filing with the SEC. The fund owned
Abbott edges out Boston Scientific in the MedTech faceoff, with valuation appeal, strong CGM momentum and strategic deals boosting its investment case.
New York, New York--(Newsfile Corp. - February 19, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation
NEW YORK, Feb. 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such invest
Sometimes the best new ideas are simply old winners ready for another run.
Boston Scientific Corporation (NYSE: BSX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twenty-four analysts that are covering the stock, Marketbeat.com reports. Three r
Insightful Analysis of Lee Ainslie (Trades, Portfolio)'s Fourth Quarter 2025 13F Filing Lee Ainslie (Trades, Portfolio) recently submitted the 13F filing for t
Atria Investments Inc boosted its position in shares of Boston Scientific Corporation (NYSE: BSX) by 85.8% during the undefined quarter, according to its most recent 13F filing with the Securities and
Insights from Frank Sands (Trades, Portfolio)' Fourth Quarter 2025 13F Filing Frank Sands (Trades, Portfolio) recently submitted the 13F filing for the fourth
Boston Scientific  BSX reported its fourth-quarter 2025 results on Feb. 4. Both top and bottom lines exceeded the company's guidance ranges and topped the respective Zacks Consensus Estimate.
MARLBOROUGH, Mass., Feb. 13, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 46th Annual Health Care Conference on Tuesday, March 3, 2026.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE